First-line treatment of advanced ALK-positive non-small-cell lung cancer

Shipra Gandhi,1 Hongbin Chen,2 Yujie Zhao,2 Grace K Dy2 1Department of Internal Medicine, State University of New York, 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA Abstract: Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer deaths, both within th...

Full description

Bibliographic Details
Main Authors: Gandhi S, Chen H, Zhao Y, Dy GK
Format: Article
Language:English
Published: Dove Medical Press 2015-09-01
Series:Lung Cancer : Targets and Therapy
Online Access:https://www.dovepress.com/first-line-treatment-of-advanced-alk-positive-non-small-cell-lung-canc-peer-reviewed-article-LCTT